Bioptix Diagnostics, Inc.

UEI
C9S9MK6LSNV1
CAGE
3M6B4
Primary NAICS
334516 Analytical Laboratory Instrument Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
  • Contracts and Grants
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Surface plasmon resonance instrument HHSN271201500074A National Institute on Drug Abuse (NIH) $149,500
Topic 281 phase i sbir HHSN261201000126C National Cancer Institute (NIH) $150,000
Sbir phase i - real time novel holographic monitoring of airborne trace contaminants onboard space vessels NNC05CA71C Glenn Research Center $69,799

Grant awards

Award Agency Obligated Awarded
Rapid label-free multiplex detection of micrornas R43CA153467 National Institutes of Health $99,521
Sbir phase i: a robust optical biosensor for cardiac diagnostics 0740695 National Science Foundation $100,000
A real-time, label-free diagnostic platform with glycan arrays R43RR024293 National Institutes of Health $200,000
A novel holographic detector for remote sensing of environmental hazards R43ES014512 National Institutes of Health $35,287

Quick answers

Is Bioptix Diagnostics, Inc. registered in SAM.gov?

Bioptix Diagnostics, Inc.'s SAM.gov registration expired on August 18, 2016.

What is Bioptix Diagnostics, Inc.'s most recent federal award?

Bioptix Diagnostics, Inc.'s most recent federal contract award is Surface plasmon resonance instrument (HHSN271201500074A), from National Institute on Drug Abuse (NIH), on September 21, 2015.

On GovTribe

See Bioptix Diagnostics, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login